People · Operator
Named in public records as an officer, director or promoter · active 2024–2026 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Atomwise Inc. | — | Biotechnology | Series D+ | $238.6M | $124.4M | 2024 |
Stephen Worland at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Worland on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matt Ocko | 1 | 13 |
| Robert Mittendorff | 1 | 5 |
| Adam Seabrook | 1 | 5 |
| Kiersten Stead | 1 | 4 |
| Raj Ganguly | 1 | 4 |
| Gavin Teo | 1 | 3 |
| Linda Maxwell | 1 | 2 |
| Mike Varney | 1 | 1 |
| Han Lim | 1 | 1 |
| Yan Zhao | 1 | 1 |
| Abraham Heifets | 1 | 1 |
| Izhar Wallach | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.